(R)-Thalidomide NEW
| Price | $64 | $147 | $228 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2026-04-21 |
Product Details
| Product Name: (R)-Thalidomide | CAS No.: 2614-06-4 |
| Purity: 99.87% | Supply Ability: 10g |
| Release date: 2026/04/21 |
Product Introduction
Bioactivity
| Name | (R)-Thalidomide |
| Description | (R)-Thalidomide is a COX 1/2 inhibitor that induces apoptosis in MCF-7, IM-9, HS-Sultan, KB and other cancer cells. |
| In vitro | With the affinity of (R)-Thalidomide by the MIP present surface capture, that is more strongly than the other forms. In the case of (R)-Thalidomide, it is found to bind to the selective sites of the MIP more strongly than the other which reflects their different biological entities[1]. The (S)-Thalidomide imprints MIP nanoparticles exerted a greater cytotoxic effect on the caco-2 cells than the (R)-Thalidomide imprinted MIPs[1]. |
| In vivo | Methods: Adult female F344 rats were implanted with 9L gliosarcoma tumors intracranially, subcutaneously (flank), or both. The efficacy of oral thalidomide alone and in combination with intraperitoneal BCNU or cisplatin was evaluated after several weeks of treatment. S- and (R)-Thalidomide were measured by chiral HPLC in presumed pseudo-steady-state serum, tumor, and other tissues collected after treatment. Results: Serum and tissue concentrations of (R)-Thalidomide were 40-50% higher than those of (S)-Thalidomide. [1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 10 mg/mL (38.73 mM), Sonication is recommended. |
| Keywords | Thalidomide | (R)Thalidomide | (R) Thalidomide |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Urea | Guanidine hydrochloride | Hydroxychloroquine | Metronidazole | Formamide | Paeonol | Naringin | Trometamol | Alginic acid |
| Related Compound Libraries | Bioactive Compound Library | Neuronal Signaling Compound Library | Inhibitor Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $/ |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $690.00/10kilograms |
VIP4Y
|
Hebei Dangtong Import and export Co LTD
|
2023-02-17 | |
| $97.00/500mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-04-21 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY